| EPB0265 | Evaluating the perceptions of PWID about long-acting MOUD, PrEP, and ART | E-poster | Clinical issues specific to key populations |
| EPB0266 | Mpox knowledge, concern, willingness to change behaviour, and seek vaccination in Australia: results of a national cross-sectional survey | E-poster | Clinical issues specific to key populations |
| EPB0267 | Factors associated with viral load suppression amongst transgender people in South Africa | E-poster | Clinical issues specific to key populations |
| EPB0268 | The role of substance use in structural heart disease among unsheltered and unstably housed women living with HIV | E-poster | Clinical issues specific to key populations |
| EPB0269 | Review of antiretroviral therapy coverage among prisoners living with HIV in 10 African countries | E-poster | Clinical issues specific to key populations |
| EPB0127 | Effects of direct-acting antiviral therapy on immunologic and hepatic markers among people with HIV/HCV coinfections | E-poster | Co-infections (including opportunistic infections) |
| EPB0128 | Implementation of HCV treatments among people living with HIV/HCV in Washington, DC | E-poster | Co-infections (including opportunistic infections) |
| EPB0129 | Role of low-risk HPV PCR in screening for HSIL lesions and anal cancer in men who have sex with men (MSM) living with HIV (MSM-LWHIV) | E-poster | Co-infections (including opportunistic infections) |
| EPB0130 | Integration of human papillomavirus-based cervical cancer screening into HIV care for women living with HIV in Ethiopia | E-poster | Co-infections (including opportunistic infections) |
| EPB0131 | CD4+ T cell recovery in HIV/HCV co-infected patients following HCV treatment | E-poster | Co-infections (including opportunistic infections) |